Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|February 5, 2024
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonistsJessica N Filderman, Jennifer L Taylor, Jianmin Wang, et al.
Scientific Reports|May 15, 2025
Chronic rejection models for vascularized composite tissue allotransplantationDaniel T Fisher, Emily Mackey, Eugene Kononov, et al.
Breast Cancer Research and Treatment|January 9, 2022
Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center studyMaithreyi Sarma, Stuthi Perimbeti, Samar Nasir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib StudyDevalingam Mahalingam, Grey A Wilkinson, Kevin H Eng, et al.
Cancers|August 14, 2025
Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV BiomarkersShin-La Shu, Shawna Benjamin-Davalos, Xue Wang, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2010
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersXinmei Zhu, Beth A Fallert-Junecko, Mitsugu Fujita, et al.
Molecular Pharmaceutics|April 1, 2026
Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder CancerFarukh A Durrani, Joseph Cacaccio, William Potter, et al.
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumorsKotaro Sasaki, Angela D Pardee, Yanyan Qu, et al.
Vaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.
Pageof 15